Lund OsteoArthritis Division - Molecular marker research group
1 – 10 of 195
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Reframing early-stage symptomatic knee osteoarthritis (EsSKOA) : A strategic lens for trial design
(2026) In Osteoarthritis and Cartilage
- Contribution to journal › Debate/Note/Editorial
-
Mark
Change in the chondroitin/dermatan structure in distal lung tissue from COPD patients
- Contribution to journal › Article
-
Mark
Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis
- Contribution to journal › Article
-
Mark
Inhibition of Dermatan Sulfate Epimerase 1 by Substituted Glucuronic Acids
- Contribution to journal › Article
-
Mark
Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis
(2026) In Nature Cell Biology
- Contribution to journal › Article
-
Mark
The role of metabolic syndrome in osteoarthritis development : Is obesity the key driver?
- Contribution to journal › Article
- 2025
-
Mark
Longitudinal stability of molecular endotypes of knee osteoarthritis patients
- Contribution to journal › Article
-
Mark
Multi-centre modified Delphi exercise to identify candidate items for classifying early-stage symptomatic knee osteoarthritis
- Contribution to journal › Article
-
Mark
Response to the comment on 'The coexistence of diabetes, hypertension and obesity is associated with worse pain outcomes following exercise for osteoarthritis: A cohort study on 80 893 patients'
- Contribution to journal › Letter
-
Mark
Reliability of digitally instructed self-reported 30-second Chair Stand Test for lower extremity function
- Contribution to journal › Article
